Novo Nordisk to phase out human insulin pens: report
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
CTV News10h
Needleless insulin device being introduced in Canada on World Diabetes Day
InsuJet [is] the first device to Canada that actually has no needles,” said Daphne Lapenna of Sol-Millennium Medical Ltd. who ...